Literature DB >> 1975747

MK-801-induced stereotypy and its antagonism by neuroleptic drugs.

P I Tiedtke1, C Bischoff, W J Schmidt.   

Abstract

MK-801 [(+)-5-methyl-10,11-dihydroxy-5H-dibenzo-(a,d)cyclohepten-5,10-imi ne hydrogen maleate], which blocks glutamatergic transmission at the NMDA-receptor-gated ion channel, induced stereotypies which are similar to those found after intrastriatal injections of AP-5, e.g. sniffing and locomotion. Tests in familiar or unfamiliar environment (non-stressful or stressful situation) did not qualitatively change MK-801-induced effects. Haloperidol (0.1 mg/kg, IP) delayed the onset and shortened the duration of MK-801 (0.16; 0.33 mg/kg, IP)-induced stereotypy whereas clozapine (5 mg/kg, SC) potently antagonized it. However, exact quantification of sniffing, measured in an experimental chamber designed for this purpose, revealed an antagonism by both drugs, haloperidol as well as clozapine. Stereotypy is considered to represent an animal model of schizophrenia, and the antagonism of stereotypy with classical (haloperidol) as well as with atypical (clozapine) antipsychotic drugs is in accordance with the glutamate hypothesis of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975747     DOI: 10.1007/bf01245040

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  18 in total

1.  Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.

Authors:  S F Calderon; P R Sanberg; A B Norman
Journal:  Brain Res       Date:  1988-05-31       Impact factor: 3.252

2.  Environmental stimuli but not homeostatic challenges produce apparent increases in dopaminergic activity in the striatum: an analysis by in vivo voltammetry.

Authors:  R W Keller; E M Stricker; M J Zigmond
Journal:  Brain Res       Date:  1983-11-21       Impact factor: 3.252

3.  Phencyclidine.

Authors:  S H Snyder
Journal:  Nature       Date:  1980-06-05       Impact factor: 49.962

4.  Behavioural effects of N-methyl-D-aspartate in the anterodorsal striatum of the rat.

Authors:  W J Schmidt; D Bury
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

5.  Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats.

Authors:  W J Schmidt; M Bubser
Journal:  Pharmacol Biochem Behav       Date:  1989-03       Impact factor: 3.533

6.  Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum.

Authors:  P H Kelly; P W Seviour; S D Iversen
Journal:  Brain Res       Date:  1975-09-05       Impact factor: 3.252

7.  MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.

Authors:  W Koek; J H Woods; G D Winger
Journal:  J Pharmacol Exp Ther       Date:  1988-06       Impact factor: 4.030

8.  Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors.

Authors:  P R Sanberg
Journal:  Nature       Date:  1980-04-03       Impact factor: 49.962

9.  Intrastriatal injection of DL-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine.

Authors:  W J Schmidt
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

10.  Interactions between dopamine and amino acid-induced excitation and inhibition in the striatum.

Authors:  L A Chiodo; T W Berger
Journal:  Brain Res       Date:  1986-06-04       Impact factor: 3.252

View more
  33 in total

1.  Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats.

Authors:  D C Hoffman
Journal:  J Neural Transm Gen Sect       Date:  1992

2.  Proteome analyses of cultured astrocytes treated with MK-801 and clozapine: similarities with schizophrenia.

Authors:  Daniel Martins-de-Souza; Maria Lebar; Christoph W Turck
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-11-19       Impact factor: 5.270

3.  Anticataleptic potencies of glutamate-antagonists.

Authors:  W J Schmidt; B Zadow; B D Kretschmer; W Hauber
Journal:  Amino Acids       Date:  1991-06       Impact factor: 3.520

4.  Synergistic interactions between NMDA-antagonists and L-dopa on activity in MPTP-treated mice.

Authors:  A Fredriksson; C Gentsch; T Archer
Journal:  J Neural Transm Gen Sect       Date:  1994

5.  The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801.

Authors:  D C Hoffman; H Donovan; J V Cassella
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats.

Authors:  A Ouagazzal; A Nieoullon; M Amalric
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Centrally-administered glycine antagonists increase locomotion in monoamine-depleted mice.

Authors:  B Stauch Slusher; K C Rissolo; P F Jackson; L M Pullan
Journal:  J Neural Transm Gen Sect       Date:  1994

8.  Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats.

Authors:  K Wedzony; K Gołembiowska; M Zazula
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

9.  A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice.

Authors:  A Svensson; E Pileblad; M Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1991

10.  Antidepressant drugs increase the locomotor hyperactivity induced by MK-801 in rats.

Authors:  J Maj; Z Rogóz; G Skuza
Journal:  J Neural Transm Gen Sect       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.